NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Harrow Health, Inc.
HROW
Harrow Health, Inc. CEO Mark L. Baum · Market cap $1.6B.
$42.07
+0.57 · +1.37%
52w hi $54.8552w lo $28.54
Off 52w high 44.1%
71
NOTABLE
Current InsiderScore
Corp · 90d
4
4 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
4
0 strong · 4 notable
Analyst consensus
Strong Buy
Avg PT $73.67
Section 01
Recent Form 4 filings
7 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| May 18 | Lauren P Silvernail | Buy | 1,000 | $31.00 | +$31K | 70 | |
| May 18 | Adrienne L Graves | Buy | 1,000 | $31.07 | +$31K | 70 | |
| May 14 | Andrew R. Boll | PRESIDENT AND CFO | Buy | 3,500 | $29.90 | +$105K | 68 |
| May 14 | Mark L Baum | CHIEF EXECUTIVE OFFICER | Buy | 10,000 | $30.20 | +$302K | 71 |
| Mar 04 | Opaleye Management Inc. | Sell | 134,000 | $39.67 | −$5.32M | 29 | |
| Mar 03 | Opaleye Management Inc. | Sell | 59,000 | $39.15 | −$2.31M | 26 | |
| Jan 06 | Opaleye Management Inc. | Sell | 20,000 | $53.35 | −$1.07M | 32 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun